Boxer Capital Management’s Precigen PGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding PGEN
PCM
DC
TCM
IAM
OCM
Boxer Capital Management's PGEN Position: Q2 2026 in Review
Boxer Capital Management increased its Precigen (PGEN) stake by 47% in Q2 2026, buying an estimated $7.13M and bringing the position to 5,150,000 shares worth $29.4M. The position accounts for 2.21% of the portfolio, ranked #12.
Boxer Capital Management first reported a position in PGEN in Q3 2025 and has held it in 4 quarters since. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.
- Boxer Capital Management held 5,150,000 shares of Precigen worth $29.4M as of Q2 2026.
- Boxer Capital Management bought 1,650,000 Precigen shares in Q2 2026, an estimated $7.13M.
- Precigen made up 2.21% of Boxer Capital Management's portfolio in Q2 2026, its #12 holding.
- Boxer Capital Management first reported a position in Precigen in Q3 2025 and has held it in 4 quarters since.
- 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.
Based on Boxer Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.